Related Experiment Video
Updated: May 14, 2026

06:10
A Simple Double Centrifugation Tube Method to Obtain Platelet-rich Plasma from Equine Blood
Published on: August 15, 2025
Plasma concentrations of inflammatory markers in previously laminitic ponies
H Wray1, J Elliott, S R Bailey
1Royal Veterinary College, London, UK.
Equine Veterinary Journal
|February 20, 2013
Summary
Previously laminitic ponies had lower adiponectin, an anti-inflammatory marker, suggesting reduced anti-inflammatory capacity. This study investigated inflammatory profiles in ponies with and without a history of laminitis.
Area of Science:
- Equine Health
- Veterinary Immunology
- Animal Physiology
Background:
- Pasture-associated laminitis predisposition mechanisms are unclear, though chronic inflammation is suspected.
- Understanding inflammatory profiles is crucial for identifying at-risk animals.
Purpose of the Study:
- To compare inflammatory profiles between previously laminitic (PL) and non-laminitic (NL) ponies.
- To assess seasonal variations (late spring vs. winter) in inflammatory markers.
Main Methods:
- Blood samples were collected from PL (n=38-42) and NL (n=39-41) ponies in late spring and winter.
- Assayed plasma concentrations of adiponectin, tumor necrosis factor-α, serum amyloid A, haptoglobin, insulin, triglyceride, fibrinogen, IL-17, IL-4, and interferon-γ.
- Used multivariate analysis to identify factors associated with cytokine levels.
Main Results:
- Previously laminitic ponies had significantly lower plasma adiponectin concentrations than control ponies.
- Plasma triglyceride concentrations were higher in previously laminitic ponies.
- Seasonal and gender differences were observed in fibrinogen, serum amyloid A, haptoglobin, IL-4, and insulin levels.
Conclusions:
- Reduced adiponectin in previously laminitic ponies suggests a diminished anti-inflammatory capacity.
- Recurrent laminitis may be linked to reduced anti-inflammatory capacity rather than a proinflammatory state.
- Season and gender significantly influence various inflammatory mediators.

